<ul><li>An accurate, non-invasive blood test by Sunbird Bio could revolutionize neurological diagnostics.</li><li>The blood-based technology enables early intervention strategies and tailored treatments for patients.</li><li>Sunbird benefits from a strong leadership team and strategic partnerships with biopharma companies.</li><li>Investors like Eli Lilly and EDBI support Sunbird Bio in bringing their diagnostic technology to market.</li></ul>

Sunbird Bio: Revolutionising Neurological Diagnostics with Blood-Based Technology

Discover more